Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Research and Development
Synergy opens registry to advance neurodegenerative disease research
Development services : 26 August, 2011
Synergy Health Concepts is developing a registry to advance research regarding venous vascular obstructions in neurodegenerative diseases.
 
Multi-million pound funds agreed for two new research units in London
Research institutes : 22 August, 2011
Two NHS Trusts in partnership with Imperial College London receive multi-million pound awards to boost research and enable the development of more effective medicines, treatments and care for patients.
 
Dr Brian Jones wins 2011 Oxoid W H Pierce Memorial Prize
Research studies : 03 August, 2011
The 2011 Oxoid W H Pierce Memorial Prize, which commemorates the late W H (Bill) Pierce, has been awarded to Dr Brian Jones, Senior Lecturer at the University of Brighton, England. The award acknowledges Dr Jones' research into the human gut mobile metagenome, the mobile genetic elements (such as plasmids) that are associated with gut microbiota.
 
GMEC public private partnership provides framework for collaborative science
Research institutes : 15 April, 2011
The Medical Research Council (MRC), Imperial College London, King's College London and UCL are forming a partnership that will see them become equal shareholders in a newly created joint venture that assumes responsibility for the facilities and operations at GlaxoSmithKline’s Clinical Imaging Centre (CIC).
 
Mayo Clinic discovers tool to predict disability timeline for progressive MS patients
Research studies : 14 April, 2011
By noting the presence of certain markers in a commonly performed diagnostic test for progressive multiple sclerosis (MS), Mayo Clinic researchers is able to predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety.
 
Caliper partners Catholic Health Initiatives to evaluate new cancer drugs
Development services : 07 April, 2011
Caliper Life Sciences’ Caliper Discovery Alliances and Services (CDAS) unit is forming a research collaboration with Denver-based Catholic Health Initiatives (CHI), one of the USA's largest health systems.
 
PRECOS extends alliance with Argenta to offer drug discovery services
Development services : 23 March, 2011
Preclinical Oncology Services (PRECOS) is extending its alliance with Argenta to continue providing comprehensive oncology-focused drug discovery services.
 
SLaM runs two treatment trials for young people with OCD
Research studies : 10 March, 2011
Two innovative trials to help improve the treatment of young people with obsessive compulsive disorder (OCD) are currently being run by SLaM’s Obsessive Compulsive Disorder Service.
 
SNPs are linked with high risk of sick sinus syndrome
Research studies : 08 March, 2011
Scientists at deCODE genetics together with academic colleagues from Iceland, The Netherlands, Denmark, USA and Illumina are reporting the discovery of single-letter variants (SNPs) in the sequence of the human genome associated with high risk of sick sinus syndrome (SSS).
 
PRECOS webinar focuses on in-vitro and in-vivo modelling of human TME
Development services : 04 March, 2011
Preclinical Oncology Services is to host a new webinar that focuses on the company's cutting-edge technology and innovative ideas on in-vitro and in-vivo modelling of the human tumour micro-environment (TME).
 
PRECOS doubles capacity to support oncology drug discovery expansion
Development services : 15 February, 2011
Preclinical Oncology Services is doubling its capacity to support the strategic growth of the company following the first six months since its spin-out from the University of Nottingham in September 2010.
 
Imperial College London launches new School of Public Health
Research institutes : 15 February, 2011
Imperial College London is launching a new School of Public Health with the aim of addressing the major global health challenges of the 21st century.
 
Clinical trial evaluates NP2 Enkephalin as an effective NTDDS candidate
Research studies : 14 February, 2011
Diamyd Medical's US Phase II clinical trial, evaluating the ability of the candidate drug NP2 Enkephalin to reduce cancer pain, is now posted on the ClinicalTrials.gov website.
 
Diagnostics and Medical Imaging – Research
Research studies : 28 January, 2011
FOCUS ZONE REPORT – Scientists from Sweden’s University of Gothenburg report that two relatively simple methods, an ultrasound investigation and a blood test to measure the level of a substance known as BNP, can predict survival and future heart failure following acute coronary syndromes.
 
Cancer treatment prototype features 3D magnetically guiding endoscope system
Research institutes : 27 January, 2011
A Taiwanese research team, led by Prof Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), develops a large-scale proactive cancer treatment system first-generation prototype which includes Frequency-Adjustable High Frequency Induction Heating Machine (HFIHM) and 3D Magnetically Guiding Endoscope System (3DMGES).
 
Diamyd begins Phase II clinical trial in USA for evaluating NP2 Enkephalin
Development services : 19 January, 2011
Diamyd doses the first subject in a Phase II clinical trial in the USA evaluating the ability of the candidate drug NP2 Enkephalin to reduce cancer pain.
 
University of Michigan pinpoints new way of attacking breast cancer stem cells
Research studies : 19 January, 2011
A potential new way of attacking breast cancer stem cells, the small number of cells in a tumour that fuel its growth and spread, is identified by scientists at the University of Michigan Comprehensive Cancer Center.
 
Researchers discover set of SNPs to identify prostate specific antigen levels
Research studies : 20 December, 2010
Scientists from deCODE genetics and academic colleagues from Iceland, the UK, US, Netherlands, Spain and Romania are reporting the discovery of a set of single-letter variations in the sequence of the human genome (SNPs) that impact individual baseline levels of prostate specific antigen, or PSA.
 
St Jude Children's Research Hospital reports new brain development mechanism
Research studies : 29 November, 2010
St Jude Children's Research Hospital scientists is reporting new details about mechanisms regulating a crucial step in brain development, offering insight into the origins of epilepsy, mental retardation and possibly brain tumour metastasis
 
Tufts University School of Medicine find how to halt breast cancer stem cell growth
Research studies : 29 November, 2010
Researchers from the Tufts University School of Medicine report that they are able to halt the expansion of Breast cancer stem cells (CSCs) which paves the way for a new drug therapy target.
 
Study indicates aggressive surgery is best for children with brain tumours
Research studies : 24 November, 2010
A new Mayo Clinic study finds that children with low-grade brain tumours (gliomas) who undergo aggressive surgery to completely remove the tumour have an increased chance of overall survival.
 
PRECOS signs a global oncology service deal with Janssen Pharmaceutical
Development services : 23 November, 2010
Preclinical Oncology Services (PRECOS) signs a global service agreement with a leading global pharmaceutical company Janssen Pharmaceutical which will see PRECOS provide clinical tumour material, tumour model development, target validation and drug efficacy work to support Janssen's oncology drug discovery, development and biomarker programmes.
 
Imperial College London reveals new Institute of Chemical Biology
Research institutes : 17 November, 2010
Imperial College London’s Chemical Biology Centre is being reconstituted as the Institute of Chemical Biology (ICB) to join other cross-Faculty Institutes that have the task of bridging world-class research activity in the different faculties and departments within the College.
 
Quotient Bioresearch opens new radiochemistry facility in Cardiff, UK
Development services : 14 September, 2010
Quotient Bioresearch opens the company’s new, state-of-the-art radiochemistry facility in Cardiff, UK, with a ceremony including a VIP opening by the First Minister of Wales, Carwyn Jones.
 
University spin-out offers new pre-clinical research and development service
Development services : 10 September, 2010
Preclinical Oncology Services (PRECOS), a leading pre-clinical research and development service with a specific focus on oncology, is launched following its spin-out from the University of Nottingham.
 
NTU in Singapore plans new medical school tfor raining undergraduate doctors
Research institutes : 06 September, 2010
A new medical school training undergraduate doctors in Singapore, which will award joint Imperial College London and Nanyang Technological University (NTU) degrees , is to be established by 2013.
 
Vaccines reduces bacterial pneumonia cases in children
Development services : 31 August, 2010
The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, reports a new study which was led by Dr Sonia Saxena of the School of Public Health at Imperial College London.
 
Study shows non-viral gene therapy may prevent retinal degeneration
Research studies : 23 August, 2010
A new study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision.
 
Philips joins Gilde Healthcare III fund for patient-centric healthcare solutions
Development services : 23 August, 2010
Philips joins Gilde Healthcare III - a new venture capital fund focusing on innovative early and growth stage healthcare technology companies in Europe and the USA that are active in developing and commercialising new patient-centric healthcare solutions, medical technologies and therapeutics.
 
Agendia unveils new state-of-the-art genomics laboratory in California
Development services : 09 August, 2010
Agendia inaugurates a new state-of-the-art clinical genomics laboratory in Irvine, California, USA.
 
Eppendorf invites entrants for Young European Investigators Award
Research studies : 26 July, 2010
Young researchers working in Europe who are not older than 35 years are being invited to apply for the Eppendorf Award for Young European Investigators.
 
Genomics-based research shows the origin of cancer subgroups
Research studies : 20 July, 2010
An international team led by St Jude Children's Research Hospital scientists develops a new approach that uses genomic information from different species to understand the biology that drives the formation of different cancer subtypes.
 
deCODE finds genetic risk factor linking susceptibility to four vascular diseases
Research studies : 15 July, 2010
Scientists from deCODE genetics together with academic colleagues from the Netherlands and twelve other countries across Europe and North America are reporting the discovery of a common single-letter variation (SNP) in the sequence of the human genome conferring risk of a range of vascular diseases.
 
BioHub launches online global networking platform for biomedical research
Development services : 08 July, 2010
BioHub is launching BioHub-Online.org, a first-of- its-kind online platform to facilitate global networking and collaboration among research scientists.
 
Mayo Clinic partners with University of Illinois to develop new technologies
Development services : 28 June, 2010
Mayo Clinic and the University of Illinois at Urbana-Champaign agree a strategic alliance designed to promote a broad spectrum of collaborative research, development of new technologies and clinical tools, and design and implementation of novel education programmes.
 
First SynCardia Total Artificial Heart Patient is discharged in the USA
Development services : 01 June, 2010
Mayo Clinic Arizona becomes the first hospital in US history to discharge a patient implanted with the SynCardia temporary Total Artificial Heart to wait at home for a matching donor heart.
 
PA Consulting collaborates with 4D Biomedical to develop experimental medicine
Development services : 16 February, 2010
Leading international technology, management and systems consultancy, PA Consulting Group, enters into a strategic agreement with 4D Biomedical, the Cambridge-based specialist Experimental Medicine consultancy, to support the establishment of new collaborations between NHS Trusts, leading biomedical research universities and industry partners to accelerate medical advances, both clinical and value-based.
 
Centre for Therapeutics Discovery makes first call for drug targets
Development services : 05 February, 2010
A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) to fast-track the discovery and development of novel drugs is making its first call for targets.
 
Eppendorf Award for Young European Investigators declares new deadline
Development services : 04 February, 2010
The Eppendorf Award for Young European Investigators acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.
 
deCODE discovers genetic factors for key clinical measurements of heart activity
Development services : 12 January, 2010
Scientists at deCODE genetics report the discovery of seven novel and common single-letter variations in the sequence of the human genome (SNPs) that are involved in modulating the electrical impulses that govern the working of the heart.
 
University of Western Australia reseachers point to early treatment of tinnitus
Research institutes : 18 December, 2009
Pioneering new research funded by RNID reveals hope for the early treatment of tinnitus.
 
deCODE discovers genetic influence on type 2 diabetes
Research studies : 17 December, 2009
Scientists at deCODE genetics reports the discovery of a version of a common single-letter variant in the sequence of the human genome (SNP) with a major impact on susceptibility to type 2 diabetes (T2D).
 
Imperial College opens Centre for Bio-Inspired Technology
Research institutes : 14 December, 2009
The Imperial College London Centre for Bio-Inspired Technology, which opens in December 2009, forms part of the College’s Institute of Biomedical Engineering.
 
HIV therapy trial begins using engineered T cell receptors
Research studies : 13 October, 2009
Trial begins to demonstrate that HIV patients’ cells carrying engineered T cell receptors can slow down or prevent the development of AIDS
 
Non-invasive electon microscopy for living tissue
Research institutes : 08 October, 2009
Researchers at MIT have developed a scheme enabling the use of electron microscopes to remotely sense objects and avoid damage to the imaged target
 
Retinal implant developed by MIT scientists
Research institutes : 25 September, 2009
Age-related macular degeneration could be treated with retinal implant linked to camera for improved vision
 
Antibody stabilisation methods developed at Argonne
Research institutes : 07 September, 2009
Argonne National Laboratory scientists have developed a way of improving antibody stability making them useful outside the laboratory and enabling improved detection and diagnostics
 
Two new powerful HIV antibodies discovered
Research institutes : 07 September, 2009
Antibodies found by AIVI associate researchers could turn out to be the Achilles heal of the virus
 
BBSRC awards £3m grant to Imperial College London for bacterial pathogen research
Research studies : 03 August, 2009
A new cross-faculty research programme to investigate how dangerous bacterial pathogens manage to survive in the stressful environment of the human body is launched at Imperial College London, thanks to a £3 million grant from the Biotechnology and Biological Sciences Research Council (BBSRC).
 
Agilent Foundation partners Ideker Laboratory to support leukemia research
Research studies : 13 July, 2009
The Agilent Foundation, supported by Agilent Technologies is collaborating to support leukemia research at the Ideker Laboratory at the University of California, San Diego, USA .
 
First | Prev  | 1 | 2 | 3 | 4 | 5 | 6  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo